<DOC>
	<DOCNO>NCT00536445</DOCNO>
	<brief_summary>The present protocol demonstrate feasibility efficacy newly develop mode mechanical ventilation , Neurally Adjusted Ventilatory Assist , commonly know NAVA . During NAVA , time magnitude pressure deliver control infant ' diaphragm electrical activity ( EAdi ) , validate measurement neural respiratory drive . Recent clinical trial adult term infant show NAVA synchronous conventional pressure support ventilation , NAVA deliver low mean airway pressure achieve ventilation respiratory muscle unload . NAVA recently approve use neonate Health Canada FDA United States , commercially available Servoi ventilator ( Maquet Critical Care , Solna , Sweden ) . The present protocol design `` case study '' researcher responsible would like evaluate feasibility efficacy ventilate premature baby NAVA Servoi 12 hour .</brief_summary>
	<brief_title>Use NAVA Intubated Preterm</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<criteria>Preterm newborn ( &gt; 1 day postnatal age , gestational age &gt; 23 week , birth weight &lt; 1250g ) , intubate mechanically ventilate , breathe spontaneously , define ability trigger ventilator . The infant breathing conventional ventilation ( SIMV , assist control , pressure support ) follow ventilator parameter : assist control/pressure support &lt; 22 cm H2O , PEEP 46 cm H2O Fi02 &lt; .30 Pneumothorax , degenerative neuromuscular disease , bleed disorder , cardiovascular instability , cyanotic congenital cardiovascular disease , phrenic nerve damage/diaphragm paralysis , esophageal perforation , use high frequency oscillatory jet ventilation , contraindication change NG tube , infant deem `` unstable '' clinical team . The use narcotic exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>NAVA</keyword>
	<keyword>Preterm</keyword>
	<keyword>Case study</keyword>
</DOC>